Fractyl Health Inc. (NASDAQ:GUTS) does about 365.37K shares in volume on a normal day but saw 1517529 shares change hands in the recent trading day. The company now has a market cap of 132.29M USD. Its current market price is $2.76, marking an increase of 16.46% compared to the previous close of $2.37. The 52 week high reached by this stock is $14.50 whilst the lowest price level in 52 weeks is $1.74.
Fractyl Health Inc. (GUTS) has a 20-day trading average at $2.43 and the current price is -80.97% off the 52-week high compared with 58.62% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.74. If we look at the stock’s price movements over the week, volatility stands at 15.11%, which decreases to 8.95% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.68 to suggest the stock is neutral.
The consensus objective for the share price is $15.50, suggesting that the stock has a potential upside of 82.19% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
BofA Securities initiated its price target at $26.
The current price level is 13.55%, 0.66%, and -48.20% away from its SMA20, SMA50, and SMA200 respectively, with the GUTS price moving above the 50-day SMA on current market day. Fractyl Health Inc. (GUTS) stock is up 5.75% over the week and 7.81% over the past month. Its price is -78.52% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at -0.5 and -1.33 for whole year.
To reach the target analysts have set, the stock logically needs to grow 82.19 percent from here.
Outstanding shares total 47.93M with insiders holding 4.43% of the shares and institutional holders owning 84.16% of the company’s common stock. The company has a return on investment of -51.83%. Price to book ratio is 1.87 and price to sales ratio is 1102.39.
